Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Upload application in SUGAM as per new Rules: CDSCO issues notice

      Upload application in SUGAM as per new Rules: CDSCO issues notice

      Meghna A Singhania13 April 2019 1:39 PM IST
      New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has informed that uploading of applications through SUGAM...
      Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

      Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

      Meghna A Singhania12 April 2019 10:59 AM IST
      Abhay Arvind Gandhi and his wife traded in Ranbaxy shares soon after Japanese major Daiichi, in 2014, agreed to sell Ranbaxy to Sun Pharma. New Delhi:...
      Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

      Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

      Meghna A Singhania11 April 2019 10:50 AM IST
      Mumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
      Ethical Guidelines mandatory for any Biomedical Research in India: ICMR

      Ethical Guidelines mandatory for any Biomedical Research in India: ICMR

      Meghna A Singhania9 April 2019 9:32 AM IST
      New Delhi: Indian Council of Medical Research’s (ICMR) National Ethical Guidelines for Biomedical Research has become mandatory and needs to be...
      Drugs in name of medicine: STF RAID find Heroin being administered to addicts in chemist shop

      Drugs in name of medicine: STF RAID find Heroin being administered to addicts in chemist shop

      Meghna A Singhania8 April 2019 11:59 AM IST
      Peddler arrested from a chemist shop.Ludhiana: A recent raid at a chemist shop led to a discovery of drug peddling racket, where a man running the...
      Manufacturers allowed to supply Buprenorphine Sublingual Tablets to psychiatric clinics: CDSCO

      Manufacturers allowed to supply Buprenorphine Sublingual Tablets to psychiatric clinics: CDSCO

      Meghna A Singhania7 April 2019 2:00 PM IST
      New Delhi: Through a recent public notice, the Central Drugs Standard Control Organisation (CDSCO) has informed about the conditions for the...
      Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

      Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

      Meghna A Singhania7 April 2019 11:00 AM IST
      New Delhi: Hyderabad based biotechnology firm, Bharat Biotech is likely to face setback as the Government plans to impose a ban on export of...
      Supreme Court to directly hear contempt petition-Jail Singh Brothers if found guilty of non payment

      Supreme Court to directly hear contempt petition-Jail Singh Brothers if found guilty of non payment

      Meghna A Singhania5 April 2019 11:06 AM IST
      The Japanese firm's contempt plea against the Singh brothers seeks recovery of Rs 4,000 crore from them as directed by the Singapore tribunal.New...
      Sale of antibiotics, prescription drugs OTC; Court asks Government to reply

      Sale of antibiotics, prescription drugs OTC; Court asks Government to reply

      Meghna A Singhania5 April 2019 10:05 AM IST
      The bench was hearing a PIL filed by Anterrashtriya Upbhokta Kalyan Samiti, which sought direction to the authorities to check that the policy of...
      Government notifies Organ Preservative Solutions as DRUGS with immediate effect

      Government notifies Organ Preservative Solutions as DRUGS with immediate effect

      Meghna A Singhania4 April 2019 11:13 AM IST
      New Delhi: In a move to monitor and assure quality Organ Preservative Solutions (OPS) the Government has specified OPS as "Drugs."Through a recent...
      Prices of 21 New Drugs fixed by NPPA; Details

      Prices of 21 New Drugs fixed by NPPA; Details

      Meghna A Singhania4 April 2019 10:00 AM IST
      The NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
      NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

      NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

      Meghna A Singhania3 April 2019 6:08 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok